Cambridge Investment Research Advisors, Inc.
Position in TRIB — Trinity Biotech PLC
CIK 1419186
FAIRFIELD, IA
Position in TRIB
as of Mar 31, 2026
· filed Apr 30, 2026
Position Value
$12,031
-$5,570 QoQ
Shares Held
22,280
0.0% QoQ
Ownership
0.006%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2024
9 quarters on record
Common Shares in TRIB Over Time
Shares Held
Position Value (USD)
Position in Medical Devices
Healthcare · as of Mar 31, 2026Cambridge Investment Research Advisors, Inc. holds $100,026,792 across 24 Medical Devices names. TRIB ranks #24 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ABT |
Abbott Laboratories
|
302,423 | $31,049,769 | |
| 2 | SYK |
Stryker Corp
|
77,649 | $25,514,684 | |
| 3 | MDT |
Medtronic plc
|
224,017 | $19,411,073 | |
| 4 | GEHC |
GE HealthCare Technologies Inc.
|
85,273 | $6,069,732 | |
| 5 | BSX |
Boston Scientific Corp
|
53,823 | $3,377,393 | |
| 6 | DXCM |
Dexcom Inc
|
50,294 | $3,158,463 | |
| 7 | STE |
STERIS plc
|
10,820 | $2,392,626 | |
| 8 | EW |
Edwards Lifesciences Corp
|
28,422 | $2,276,033 |
All Filings in TRIB
Export CSV
9 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $12,031 | 22,280 | Shares | Sole | 2026-04-30 | |
| 2025-12-31 | $17,601 | 22,280 | Shares | Sole | 2026-02-05 | |
| 2025-09-30 | $23,171 | 22,280 | Shares | Sole | 2025-11-12 | |
| 2025-06-30 | $14,482 | 22,280 | Shares | Sole | 2025-07-31 | |
| 2025-03-31 | $12,699 | 22,280 | Shares | Sole | 2025-04-22 | |
| 2024-12-31 | $19,606 | 22,280 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $24,508 | 22,280 | Shares | Sole | 2024-10-28 | |
| 2024-06-30 | $47,456 | 22,280 | Shares | Sole | 2024-07-26 | |
| 2024-03-31 | $45,451 | 22,280 | Shares | Sole | 2024-04-24 | |
| No filing history on record for this holder in this stock. | ||||||